Melanoma Tumor Articles & Analysis: Older
3 articles found
During in vitro incubation researchers can administer interferon-γ-inducible protein 10 (IP10) inside platelets. Within the tumor microenvironment elevated levels of thrombin activate the IP10-platelet complex which releases its drug payload leading to substantial anti-tumor results. The IP10-loaded platelets targeted and inhibited tumor ...
Researcher Insco said that we found that CDK13 protein can play the role of tumor suppressor in melanoma, and its mutation or deletion can lead to tumor occurrence. ...
Chimeric antigen receptor T cells (CAR-T) and T cell antigen receptor chimeric T cells (TCR-T) are currently the "top stream" in adoptive T cell tumor immunotherapy. In particular, CAR-T therapy, which has been approved by the FDA, is rewriting the treatment paradigm of some hematological tumors. However, adoptive T cell therapy remains of little success in ...